Beam Therapeutics Inc at RBC Capital Markets Global Healthcare Conference Transcript
Thanks. Hello, everybody. Luca Issi, Senior Biotech Analyst here at RBC Capital Market.
And today, it's our great privilege to have Beam Therapeutics with us for a fireside chat. Representing the company, we have John Evans, Chief Executive Officer.
John, thanks so much for joining us. How are you doing today?
Great. Great to be here. Thanks for having me.
Good, good.
So we have a long list of questions here, but actually, maybe before we start asking you about the individual program, would be great if you can just talk about some of the progress that the organization has made over the last few months, and most importantly, what's ahead here for Beam?
Sounds good. So yes, Beam, of course, is working on next-generation gene editing tools,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
